Panax notoginseng (Burk.) Effects on fibrinogen and lipid plasma level in rats fed on a high-fat diet

Phytotherapy Research

Volumn 17, Issue 2, 2003, Pages 174-178

  Cicero, A F G ^a,c   Vitale, G ^b   Savino, G ^b   Arletti, R ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c G Descovich   (Italy)

Author keywords

Cholesterol; Fibrinogen; Herbal remedies; Panax notoginseng

Indexed keywords

CHOLESTEROL; FAT; FIBRINOGEN; FLUINDOSTATIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; PANAX NOTOGINSENG EXTRACT;

ADOLESCENT; ANIMAL BEHAVIOR; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG EFFECT; EXPLORATORY BEHAVIOR; FIBRINOGEN BLOOD LEVEL; GROOMING; LIPID BLOOD LEVEL; LIPID DIET; MALE; NONHUMAN; PANAX NOTOGINSENG; PLANT ROOT; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

ADMINISTRATION, ORAL; ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; DIET; DIETARY FATS; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, MONOUNSATURATED; FIBRINOGEN; HUMANS; INDOLES; LIPID METABOLISM; MALE; PANAX; PHYTOTHERAPY; PLANT PREPARATIONS; PLANT ROOTS; RATS; RATS, WISTAR; TRIGLYCERIDES;

ANIMALIA; PANAX; PANAX NOTOGINSENG;

EID: 0037328536     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1262     Document Type: Article

References (27)

1. Anderson JW, Johnstone BM, Cook-Newell ME. 1995. Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med 333: 276-282.
2. Broijersen A, Eirksson M, Wiman B, Angelin B, Hjemdahl P. 1996. Gemfibrozil treatment of combined hyperlipoproteinemia. No improvement of fibrinolysis despite marked reduction of plasma triglyceride levels. Arterioscler Thromb Vasc Biol 16: 511-516.
3. Bruneton J. 1999. Pharmacognosie. Phytochimie. Plantes Medicinales, 3rd edn. Edition Médicales Internationales: Cachan, France: 707-710.
4. Cicero AFG, Bandieri E, Arletti R. 2000. Panax notoginseng influences rat spontaneous behaviour. J Ethnopharmacol 73: 387-391.
5. Cicero AFG, Gaddi A. 2001. Rice bran oil and γ-oryzanol in the treatment of hyperlipoproteinemias and other conditions. Phytother Res 15: 277-289.
6. Clauss A. 1957. Quick method to estimate fibrinogen by a functional clotting assay. Acta Haematol 17: 237-246.
7. Feng PF, Qin NP, Qiao Q. 1999. Clinical and experimental study of improving left ventricular diastolic function by total saponins of Panax notoginseng. Chung Kuo Hsi I Chieh Ho Tsa Chih 17: 714-717.
8. Gaddi A, Cicero AFG, Dormi A, Pasquarelli V, D'Addato S. 2001. The realisation of a project aimed at reducing the plasmatic lipid level in a large Italian rural population improves the mean calcium daily intake: the Brisighella Study (BS). Eur J Clin Nutr 55: 97-106.
9. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. 1999. Dietary supplementation with ω-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevention trial. Lancet 354: 447-455.
10. Halle M, Berg A, Keul J, Baumstark MW. 1996. Association between serum fibrinogen concentrations and HDL and LDL subfraction phenotypes in healthy men. Arterioscler Thromb Vasc Biol 16: 144-148.
11. Harjai KJ. 1999. Potential new cardiovascular risk factors: left ventricular hypertrophy, homocysteine, lipoprotein(a), tryglicerides, oxidative stress and fibrinogen. Ann Intern Med 131: 376-386.
12. Jones P, Kafonek S, Laurora I, Hunninghake D, for the CURVES Investigators. 1998. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin and fluvastatin in patients with hypercholesterolemia (The CURVES Study). Am J Cardiol 81: 582-587.
13. Kwon BM, Kim MK, Baek NI et al. 1999. Acyl-CoA: cholesterol acyltransferase inhibitory activity of ginseng sapogenins, produced from the ginseng saponins. Bioorg Med Chem Lett 17: 1375-1378.
14. Kwon BM, Nam JY, Lee SH, Jeong TS, Kim YK, Bok SH. 1996. Isolation of cholesteryl ester protein inhibitors from Panax ginseng roots. Chem Pharm Bull 44: 444-445.
15. Langtry HD, Markham A. 1999. Fluvastatin. A review of its use in lipid disorders. Drugs 57: 583-606.
16. Nair DR, Papadakis JA, Jagroop IA, Mikhailidis DP, Winder AF. 1998. Statins and fibrinogen. Lancet 351: 1430-1431.
17. Ngan F, Shaw P, But P, Wang J. 1999. Molecular authentication of Panax species. Phytochemistry 50: 787-791.
18. Normann G, Streiner D. 2000. Biostatistics. The Bare Essentials, 2nd edn. B. C. Decker Inc.: Ontario, Canada: 89-162.
19. Pazzucconi F, Mannucci L, Mussoni L et al. 1992. Bezafibrate lowers plasma lipids, fibrinogen and platelet aggregability in hypertriglyceridemia. Eur J Clin Pharmacol 443: 219-223.
20. Punnonen R, Lukola A. 1984. The effect of ginseng on serum total cholesterol, HDL-cholesterol and triglycerides levels in postmenopausal women. Asia Oceania J Obstet Gynaecol 10: 399-401.
21. Qureshi AA, Abuirmeileh N, Din ZZ, Amhad Y, Burger WC, Elson CE. 1983. Suppression of cholesterogenesis and reduction of LDL cholesterol by dietary ginseng and its fractions in chicken liver. Atherosclerosis 48: 81-94.
22. 2 in blood platelets. Chung Kuo Yao Li Hsueh Pao 11: 29-32.
23. Sinzinger H, Rodrigues M. 1999. Atorvastatin and fibrinogen - a small subgroup shows extreme response. Atherosclerosis 145: 415-417.
24. Wierzbicki AS, Lumb PJ, Semra YK, Crook MA. 1998. Effect on atorvastatin on plasma fibrinogen. Lancet 351: 569-570.
25. Yamamoto M, Kugamai A, Yamamura Y. 1983a. Plasma lipid-lowering action of ginseng saponins and mechanism of the action. Am J Chin Med 11: 84-87.
26. Yamamoto M, Uemura T, Nakama S, Uemiya M, Kumagai A. 1983b. Serum HDL-cholesterol-increasing and fatty liver-improving actions of Panax ginseng in high cholesterol diet-fed rats with clinical effect on hyperlipidemia in man. Am J Chin Med 11: 96-101.
27. 1 on the synthesis of components of the fibrinolytic system in cultured smooth muscle cells of human pulmonary artery. Cell Mol Biol 43: 581-587.